We are focusing on research and development of immunotherapies for cancers, inflammatory and infectious diseases based on its patented PD-1-enhanced DNA vaccine and Anti-Δ42PD1 Antibody Immuno Blocking technology platforms; with 2 vaccines in first-in-human clinical trials.
Company Details
- Employees
- 14
- Address
- Hong Kong Science Park, Unit 712,7/f,building 12w,hong Kong
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://immunocure.hk/en/
- Keywords
- Billingshurst.
- HQ
- Hong Kong, Hong Kong
Immuno Cure Questions
Immuno Cure's website is https://immunocure.hk/en/
Immuno Cure's LinkedIn profile is https://hk.linkedin.com/company/immuno-cure
Immuno Cure has
14 employees.
View email and phone details for 14
employees at Immuno Cure.
Immuno Cure's industry is
Biotechnology Research
Immuno Cure's top competitors are
Insilico Medicine,
Bio.ai Thinktank,
Energys Group,
Pure Asia Biotech,
Great Bay Bio 大湾生物,
Centre For Virology, Vaccinology And Therapeutics,
Arbele,
Pangenia Inc,
Ampd Energy,
Geneditbio Limited.
Immuno Cure's categories are Biotechnology Research
